2 research outputs found
Structure–Activity Relationship of Amino Acid Tunable Lipidated Norspermidine Conjugates: Disrupting Biofilms with Potent Activity against Bacterial Persisters
The emergence of bacterial resistance
and biofilm associated infections
has created a challenging situation in global health. In this present
state of affairs where conventional antibiotics are falling short
of being able to provide a solution to these problems, development
of novel antibacterial compounds possessing the twin prowess of antibacterial
and antibiofilm efficacy is imperative. Herein, we report a library
of amino acid tunable lipidated norspermidine conjugates that were
prepared by conjugating both amino acids and fatty acids with the
amine functionalities of norspermidine through amide bond formation.
These lipidated conjugates displayed potent antibacterial activity
against various planktonic Gram-positive and Gram-negative bacteria
including drug-resistant superbugs such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and β-lactam-resistant Klebsiella pneumoniae. This class of nontoxic and
fast-acting antibacterial molecules (capable of killing bacteria within
15 min) did not allow bacteria to develop resistance against them
after several passages. Most importantly, an optimized compound in
the series was also capable of killing metabolically inactive persisters
and stationary phase bacteria. Additionally, this compound was capable
of disrupting the preformed biofilms of S. aureus and E. coli. Therefore, this class
of antibacterial conjugates have potential in tackling the challenging
situation posed by both bacterial resistance as well as drug tolerance
due to biofilm formation
Chitosan Derivatives Active against Multidrug-Resistant Bacteria and Pathogenic Fungi: <i>In Vivo</i> Evaluation as Topical Antimicrobials
The continuous rise of antimicrobial
resistance and the dearth
of new antibiotics in the clinical pipeline raise an urgent call for
the development of potent antimicrobial agents. Cationic chitosan
derivatives, <i>N</i>-(2-hydroxypropyl)-3-trimethylammonium
chitosan chlorides (HTCC), have been widely studied as potent antibacterial
agents. However, their systemic structure–activity relationship,
activity toward drug-resistant bacteria and fungi, and mode of action
are very rare. Moreover, toxicity and efficacy of these polymers under <i>in vivo</i> conditions are yet to be established. Herein, we
investigated antibacterial and antifungal efficacies of the HTCC polymers
against multidrug resistant bacteria including clinical isolates and
pathogenic fungi, studied their mechanism of action, and evaluated
cytotoxic and antimicrobial activities <i>in vitro</i> and <i>in vivo</i>. The polymers were found to be active against both
bacteria and fungi (MIC = 125–250 μg/mL) and displayed
rapid microbicidal kinetics, killing pathogens within 60–120
min. Moreover, the polymers were shown to target both bacterial and
fungal cell membrane leading to membrane disruption and found to be
effective in hindering bacterial resistance development. Importantly,
very low toxicity toward human erythrocytes (HC<sub>50</sub> = >10000
μg/mL) and embryo kidney cells were observed for the cationic
polymers <i>in vitro</i>. Further, no inflammation toward
skin tissue was observed <i>in vivo</i> for the most active
polymer even at 200 mg/kg when applied on the mice skin. In a murine
model of superficial skin infection, the polymer showed significant
reduction of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) burden (3.2 log MRSA reduction at 100 mg/kg) with no to minimal
inflammation. Taken together, these selectively active polymers show
promise to be used as potent antimicrobial agents in topical and other
infections